Dr Chi Chiu Mok, MD, FRCP

Dr Chi Chiu Mok, MD, FRCP

Tuen Mun Hospital
Hong Kong

Chi Chiu Mok is Chief of Rheumatology at Tuen Mun Hospital, Hong Kong. He is also the founder and Director of the Center for Treatment of Rheumatic Diseases at Pok Oi Hospital, Hong Kong. Dr Mok is the Secretary of the Accreditation Board of Rheumatology of the Hong Kong College of Physicians and is an Honorary Teaching Professor of the Chinese University of Hong Kong. He is the Principal Investigator of a number of clinical trials of novel biological agents in systemic lupus erythematosus (SLE), rheumatoid arthritis, and glucocorticoid-induced osteoporosis.

Dr Mok is on the Editorial Boards of a number of leading journals, including the International Journal of Rheumatic Diseases, Current Rheumatology Review, Immunology and Immunogenetics Insights, and The Open Rheumatology Journal. He is an ad hoc and reviewer for more than 50 rheumatology and medical journals. He is President of The Hong Kong Society of Rheumatology, and was on the organising panel for Ten Topics in Lupus, 2010 in Hong Kong.

Dr Mok’s main research interest is SLE in which he has published more than 140 first-author papers in various international peer-reviewed journals and presented more than 165 abstracts at major international meetings. Up until November 2011, he had reviewed more than 300 papers and six research grants. In addition, he was lead author of the ‘Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology’ published in 2011.


Consultant/Advisor: Pfizer

Lupus Academy Foundation
Maasdijk 409
4264 AS Veen
The Netherlands
Tel: +31 (0) 416 693 925
Email: secretariat@lupus-academy.org